We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.92%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.52B
AUM Growth
+$460M
Cap. Flow
+$410M
Cap. Flow %
16.27%
Top 10 Hldgs %
17.26%
Holding
699
New
297
Increased
110
Reduced
97
Closed
164

Sector Composition

Rank Sector Weight
1 Real Estate 21.58%
2 Consumer Discretionary 10.62%
3 Industrials 8.44%
4 Energy 7.31%
5 Technology 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMU
426
DELISTED
Immunomedics Inc
IMMU
$712K 0.03%
110,000
SHAK icon
427
Shake Shack
SHAK
$2.3B
$701K 0.03%
+21,000
New +$726K
GILD icon
428
Gilead Sciences
GILD
$161B
$689K 0.03%
10,151
-2,474
-20% -$174K
WRD
429
DELISTED
WildHorse Resource Development
WRD
$684K 0.03%
55,000
-60,000
-52% -$795K
DMTX
430
DELISTED
Dimension Therapeutics, Inc
DMTX
$683K 0.03%
390,403
+24,489
+7% +$64.9K
INCY icon
431
CALL
Incyte
INCY
$23.5B
$668K 0.03%
+5,000
New +$637K
INCY icon
432
PUT
Incyte
INCY
$23.5B
$668K 0.03%
+5,000
New +$637K
SYRS
433
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$637K 0.03%
4,000
-900
-18% -$110K
MNDT
434
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$631K 0.03%
+50,000
New +$596K
CL icon
435
Colgate-Palmolive
CL
$72.6B
$620K 0.02%
+8,469
New +$593K
ADAP
436
DELISTED
Adaptimmune Therapeutics
ADAP
$606K 0.02%
110,000
IONS icon
437
CALL
Ionis Pharmaceuticals
IONS
$9.35B
$603K 0.02%
+15,000
New +$674K
AVA icon
438
Avista
AVA
$3.47B
$586K 0.02%
+15,000
New +$588K
ALKS icon
439
Alkermes
ALKS
$8.82B
$585K 0.02%
10,000
-2,000
-17% -$113K
LAB icon
440
Standard BioTools
LAB
$326M
$569K 0.02%
100,000
AVGO icon
441
Broadcom
AVGO
$1.82T
$558K 0.02%
25,490
-125,070
-83% -$2.58M
PACB icon
442
Pacific Biosciences
PACB
$422M
$553K 0.02%
107,000
XLRN
443
DELISTED
Acceleron Pharma
XLRN
$529K 0.02%
20,000
+5,000
+33% +$132K
LLY icon
444
Eli Lilly
LLY
$1.07T
$515K 0.02%
6,126
-12
-0.2% -$961
WLH
445
DELISTED
WILLIAM LYON HOMES
WLH
$510K 0.02%
24,734
+1,835
+8% +$34.3K
BSX icon
446
PUT
Boston Scientific
BSX
$65.8B
$497K 0.02%
+20,000
New +$486K
GRA
447
DELISTED
W.R. Grace & Co.
GRA
$485K 0.02%
6,955
+3,505
+102% +$246K
CHDN icon
448
Churchill Downs
CHDN
$6.03B
$477K 0.02%
+18,018
New +$450K
INSY
449
DELISTED
Insys Therapeutics, Inc.
INSY
$473K 0.02%
45,000
+24,000
+114% +$256K
EXAS
450
DELISTED
Exact Sciences
EXAS
$472K 0.02%
20,000
-5,000
-20% -$99.1K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, Weiss Multi-Strategy Advisers held 699 positions worth $2.52B, up 22% from $2.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Weiss Multi-Strategy Advisers deployed $410M of net new capital in Q1 2017, opening 297 new positions and adding to 110 existing holdings. Its largest new stake was Invitation Homes: 1,955,084 shares worth $42.7M.

By sector, the portfolio is most concentrated in Real Estate at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $331M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q1 2017 buy was Invitation Homes: 1,955,084 shares worth $42.7M.
  • Weiss Multi-Strategy Advisers added most to First Industrial Realty Trust in Q1 2017, an estimated $22.6M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $331M.
  • Weiss Multi-Strategy Advisers fully exited Extra Space Storage in Q1 2017, selling an estimated $37.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 17% of its $2.52B portfolio in Q1 2017.
  • Weiss Multi-Strategy Advisers opened 297 new positions and closed 164 in Q1 2017.
  • Weiss Multi-Strategy Advisers's portfolio value rose 22% quarter-over-quarter to $2.52B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2017, filed 15 May 2017.